<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Ann Surg</journal-id><journal-id journal-id-type="iso-abbrev">Ann Surg</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Annals of surgery</journal-title></journal-title-group><issn pub-type="ppub">0003-4932</issn><issn pub-type="epub">1528-1140</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10439975</article-id><article-id pub-id-type="pmcid-ver">PMC10439975.319</article-id><article-id pub-id-type="pmcaid">10439975</article-id><article-id pub-id-type="pmcaiid">10439975</article-id><article-id pub-id-type="manuscript-id">NIHMS1872370</article-id><article-id pub-id-type="pmid">36805578</article-id><article-id pub-id-type="doi">10.1097/SLA.0000000000005821</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1872370</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1872370</article-id><article-version article-version-type="pmc-version">319</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Association Between Naloxone Co-Prescription Mandates and Post-Operative Outcomes</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Du</surname><given-names initials="AL">Austin L.</given-names></name><degrees>BS</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rishel</surname><given-names initials="CA">Chris A.</given-names></name><degrees>MD, PhD</degrees><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sun</surname><given-names initials="EC">Eric C.</given-names></name><degrees>MD, PhD</degrees><xref rid="A2" ref-type="aff">2</xref><xref rid="A3" ref-type="aff">3</xref></contrib></contrib-group><aff id="A1"><label>1</label>School of Medicine, University of California, San Diego, La Jolla, CA, USA</aff><aff id="A2"><label>2</label>Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California</aff><aff id="A3"><label>3</label>Department of Health Policy, Stanford University School of Medicine, Stanford, California</aff><author-notes><corresp id="CR1">Corresponding Author: Eric C. Sun, 300 Pasteur Drive, Room H3580, MC 5640, Department of Anesthesiology, Perioperative and Pain Medicine, Stanford, CA 94305, (650) 723-6412</corresp><fn fn-type="COI-statement" id="FN1"><p id="P37"><bold>Conflicts of Interest:</bold> Dr. Sun reports financial relationships, unrelated to this work, with Lucid Lane, LLC and Analysis Group, Inc.</p></fn></author-notes><pub-date pub-type="ppub"><day>01</day><month>11</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>20</day><month>2</month><year>2023</year></pub-date><volume>278</volume><issue>5</issue><issue-id pub-id-type="pmc-issue-id">443642</issue-id><fpage>e995</fpage><lpage>e1002</lpage><pub-history><event event-type="nihms-submitted"><date><day>12</day><month>02</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>01</day><month>11</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>11</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-11-01 15:25:41.700"><day>01</day><month>11</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1872370.pdf"/><abstract id="ABS1"><sec id="S1"><title>Introduction</title><p id="P1">The opioid epidemic is a public health issue in the United States. The objective of this study was to evaluate the association between naloxone co-prescription mandates and postoperative outcomes.</p></sec><sec id="S2"><title>Summary Background Data</title><p id="P2">Data on naloxone co-prescription mandates show mixed evidence for fatal overdoses in the broader population. How these mandates have impacted surgical patients has not been fully explored.</p></sec><sec id="S3"><title>Methods</title><p id="P3">Healthcare claims data were used to identify all patients undergoing 1 of 50 common procedures between January 1, 2004 and June 30, 2019 and categorized as high-risk for opioid overdose. The primary outcomes were an emergency department visit or hospital admission within 30 postoperative days. To reduce confounding, the association between this outcome and the implementation of naloxone co-prescription mandates was estimated using a difference-in-differences approach.</p></sec><sec id="S4"><title>Results</title><p id="P4">The study included 429,878 surgical patients with an average age of 54.8 years (s.d. 15.9 years) and with 257,728 females (60.0%). There was no significant association between naloxone prescribing mandates and the primary outcomes. After adjustment for potential confounders, the incidence of a hospital admission was 3.26% after implementation of a naloxone co-prescription mandate compared to 3.33% before (difference change &#8722;0.08%, 95% CI &#8722;0.44% to 0.29%, p=0.68). The incidence of an emergency department visit was 7.06% after implementation of a naloxone co-prescription mandate compared to 7.73% before (difference &#8722;0.67%, 95% CI &#8722;1.39% to 0.05%, p=0.07). These results were robust to a variety of sensitivity and subgroup analyses.</p></sec><sec id="S5"><title>Conclusion</title><p id="P5">Naloxone co-prescription mandates were not associated with statistically or clinically significant change in emergency department visits or hospital admissions within 30 postoperative days.</p></sec></abstract><abstract id="ABS2" abstract-type="summary"><title>Mini-abstract:</title><p id="P6">Naloxone co-prescription mandates are being increasingly adopted by state legislatures. Administrative healthcare claims data were used to assess the impact of these mandates, using a difference-in-differences approach to reduce confounding. Co-prescription mandates were not associated with changes in postoperative hospital admissions or emergency department visits.</p></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>